$CHEK DD by @iamjohn_c
🚨🚨 DD $CHEK 🚨🚨
Another Strong Buy now. Will very interesting for $KTOV $NOVN $AIKI members. Check-Cap is an Israeli company founded in 2005 with the vision of developing the world’s first ingestible imaging capsule system for colorectal cancer screening. WHAT? Read More 👇 pic.twitter.com/AFZHJ9wHGW— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
Check-Cap is a clinical-stage medical diagnostics company developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Watch this video. If you know anything about colon scans, it's intrusive to say the least. WATCH https://t.co/oZJiPMRQaA
— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
Reminder, this is related to $KTOV and $MRK since both are working on colorectal cancers too. This may be a great addition to $MRK. JMO. $CHECK pic.twitter.com/PRzeKA9NG3
— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
Early detection of this cancer means 93% survival probability! That's HUGE. But again, without technology like this, you end up with more people dying from this cancer than any other known cancers including Hematological. pic.twitter.com/lG9jK6vifi
— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
Since April, they've raised $11.5 In Direct Offerings, and announced first clinical trials in US starting 2021. Upcoming Catalysts: IDE Submission with FDA and getting CScan Ready. Read last sentence of this screenshot: pic.twitter.com/uLJ0hDetKj
— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
Alot of good information for you here. Pilot sales in EU starting next year, they've lined up with $GE to manufacture for US following FDA clearance. Mind you, this isn't a drug this scanner can get FDA approval faster than normal drugs like NT219. pic.twitter.com/ikAttChVYX
— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
I'll be diving in to the management later this week, but they are star studded with a board members from $GE. To sum it up: $CHEK
– sales started
– fda submission next year, delisting notic
– partner with $GE
– Partnership with big US pharma. $MRK $LLY $BMYTRADING AT $.5904. pic.twitter.com/GTHmGZBkpC
— John @ The Rock Trading Co. (@The_RockTrading) July 12, 2020
Submit your review | |
